BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22186341)

  • 21. A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
    Caronia D; Martin M; Sastre J; de la Torre J; García-Sáenz JA; Alonso MR; Moreno LT; Pita G; Díaz-Rubio E; Benítez J; González-Neira A
    Clin Cancer Res; 2011 Apr; 17(7):2006-13. PubMed ID: 21325291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency].
    Coursier S; Martelet S; Guillermet A; Emptoz J; Villier C; Bontemps H
    Gastroenterol Clin Biol; 2010 Mar; 34(3):218-23. PubMed ID: 20219304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capecitabine induced vasospastic angina.
    Coughlin S; Das S; Lee J; Cooper J
    Int J Cardiol; 2008 Oct; 130(1):e34-6. PubMed ID: 17897740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capecitabine cardiac toxicity presenting as effort angina: a case report.
    Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capecitabine-induced acute myeloid leukaemia.
    Tansley S; Gibbons S
    N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
    Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
    Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capecitabine and sixth cranial nerve palsy.
    Dasgupta S; Adilieje C; Bhattacharya A; Smith B; Sheikh Mu
    J Cancer Res Ther; 2010; 6(1):80-1. PubMed ID: 20479552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capecitabine-induced headache responding to diltiazem.
    Raman AK; Fakih MG
    Chemotherapy; 2007; 53(4):306-8. PubMed ID: 17536204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
    Do JE; Kim YC
    Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
    Kosmas C; Kallistratos MS; Kopterides P; Syrios J; Skopelitis H; Mylonakis N; Karabelis A; Tsavaris N
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):75-82. PubMed ID: 17636329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
    Advani PP; Fakih MG
    Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of capecitabine in the combined-modality therapy for rectal cancer.
    Liauw SL; Minsky BD
    Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capecitabine-induced cerebellar toxicity.
    Renouf D; Gill S
    Clin Colorectal Cancer; 2006 May; 6(1):70-1. PubMed ID: 16796795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.
    Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J
    World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
    Saif MW; Garcon MC; Rodriguez G; Rodriguez T
    In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capecitabine may induce coronary artery vasospasm.
    Tsiamis E; Synetos A; Stefanadis C
    Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capecitabine induced colitis.
    Maggo G; Grover SC; Grin A
    Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases.
    Duman BB; Paydas S; Tetiker T; Gunaldı M; Afsar CU; Erçolak V; Haksöyler V; Dilli MŞ
    Pharmacology; 2012; 90(3-4):212-5. PubMed ID: 23038659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.